SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-026105
Filing Date
2024-05-15
Accepted
2024-05-15 07:50:43
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20026311_10q.htm   iXBRL 10-Q 963832
2 EXHIBIT 31.1 ef20026311_ex31-1.htm EX-31.1 11330
3 EXHIBIT 31.2 ef20026311_ex31-2.htm EX-31.2 11016
4 EXHIBIT 32.1 ef20026311_ex32-1.htm EX-32.1 4946
5 EXHIBIT 32.2 ef20026311_ex32-2.htm EX-32.2 4944
  Complete submission text file 0001140361-24-026105.txt   5531721

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20240331.xsd EX-101.SCH 43310
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20240331_cal.xml EX-101.CAL 32344
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20240331_def.xml EX-101.DEF 240280
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20240331_lab.xml EX-101.LAB 571970
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20240331_pre.xml EX-101.PRE 372946
66 EXTRACTED XBRL INSTANCE DOCUMENT ef20026311_10q_htm.xml XML 757498
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 24947200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)